What if progress against cancer is not driven by a single breakthrough, but by changing how we understand the disease itself?
At the American Association for Cancer Research (AACR) Annual Meeting 2026, Fox Chase Cancer Center did not just share research findings. Its scientists helped shape the questions guiding where cancer research is headed next; questions about how cancer begins, how it changes over time, and how it might be stopped earlier than ever before.
That influence was visible throughout the meeting, from leadership roles to research presentations focused on earlier detection, smarter treatments, and prevention.
Helping Set the Direction for Cancer Research
One of the most influential ways Fox Chase made an impact at AACR was by helping design the meeting itself.
Edna Cukierman, PhD, served as Chair of the AACR Education Committee, shaping sessions that encouraged researchers to think beyond their own specialties. The program brought together prevention, tumor biology, technology, and treatment, helping scientists see how discoveries in one area can drive progress in another.
“The goal isn’t just learning something new,” Cukierman said. “It’s understanding how everything connects, and where we can intervene earlier, smarter, and more effectively.”
That idea of acting earlier and more precisely ran through every Fox Chase contribution at the meeting.
How Aging Changes the Way Cancer Spreads
One of the clearest themes from Fox Chase research was the growing realization that cancer does not develop in isolation. It evolves within a body that is also changing with age.
New studies presented by Mitchell Fane, PhD, and his colleagues showed that as the immune system ages, it does not simply weaken; it changes in ways that may help cancer spread.
By identifying specific immune cells involved in metastasis to organs like the lungs and liver, this work opens the door to future treatments that do more than target tumors. They could also adjust the aging immune system that surrounds them.
For patients, this could eventually mean therapies tailored not just to a diagnosis, but to how their bodies change over time.
Making the Earliest Signs of Cancer Easier to See
With multiple presentations, Fox Chase researchers shared new tools designed to detect and understand cancer earlier and more clearly.
Highlights included:
- A urine‑based test that could spot signs of bladder cancer before it returns
- Advanced 3D lab models that show how pancreatic tumors interact with surrounding cells
- New approaches to help the immune system attack cancers that typically resist treatment
Researchers also showed how artificial intelligence is being used to tackle some of cancer’s toughest targets, including pathways long considered difficult to treat.
Each of these efforts reflects a shift away from reacting to advanced disease and toward finding cancer sooner and acting with greater precision.
Stopping Cancer Before a Tumor Forms
Perhaps the most forward‑looking work on display focused on cancer interception, the idea of stopping cancer at its earliest molecular signals, before a tumor fully develops.
Fox Chase is leading this emerging area of research with work led by Margie Clapper, PhD, including the CAP‑IT program, is helping define how scientists identify people at high risk and match them with targeted preventive therapies.
This goes beyond early detection.
It points to a future where cancer may be interrupted before symptoms, scans, or diagnoses, with the potential to change the trajectory of disease.
Why This Matters Beyond the Meeting
There was no single headline‑grabbing announcement from Fox Chase at AACR, and that is the point.
What emerged instead was a clear pattern: a coordinated effort to rethink cancer from start to finish.
From how it begins, to how it spreads, to how it might be stopped before it ever becomes life‑threatening, Fox Chase is helping redefine what progress in cancer research looks like.
For patients, that shift could one day mean:
- Fewer late‑stage diagnoses
- Treatments better tailored to the individual
- New ways to stop cancer before it takes hold
The future of cancer care is not just being studied, it is beginning to take shape.